JASON LUDWIG: Open Payments
NPI 1144258534 · MERIDIAN, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,443 in 69 payments from 26 companies in 2025. Trend: 2023 $1,008 · 2024 $1,137 · 2025 $1,443
Food & beverage: $1,443
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 15 | $234 |
| AstraZeneca Pharmaceuticals LP | 6 | $167 |
| Novo Nordisk Inc | 7 | $137 |
| Otsuka America Pharmaceutical, Inc. | 5 | $97 |
| Teva Pharmaceuticals USA, Inc. | 3 | $80 |
| Aimmune Therapeutics, Inc. | 3 | $70 |
| Corcept Therapeutics | 3 | $68 |
| ABBVIE INC. | 2 | $57 |
| Amgen Inc. | 3 | $55 |
| Novartis Pharmaceuticals Corporation | 2 | $53 |
Products named: NURTEC ODT, FARXIGA, REXULTI, AUSTEDO XR, Ozempic, ZENPEP, Korlym, UBRELVY.
Industry payments across ID — which companies pay providers there.
